Vitae Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Vitae Pharmaceuticals has a total of 988 patents globally, out of which 460 have been granted. Of these 988 patents, more than 43% patents are active. The United States of America is where Vitae Pharmaceuticals has filed the maximum number of patents, followed by Europe and Japan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Vitae Pharmaceuticals. Vitae Pharmaceuticals was founded in 2001. The Company offers clinical-stage biopharmaceutical products. The Company develops small molecule compounds that address medical needs such as chronic kidney disease, diabetes, atherosclerosis and alzheimer’s diseases. Do read about some of the most popular patents of Vitae Pharmaceuticals which have been covered by us in this article and also you can find Vitae Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vitae Pharmaceuticals patent portfolio.

How many patents does the Founder of Vitae Pharmaceuticals have?

The Founder John J. Baldwin has 93 patents.

How many patents does Vitae Pharmaceuticals have?

Vitae Pharmaceuticals has a total of 988 patents globally. These patents belong to 157 unique patent families. Out of 988 patents, 427 patents are active.

How Many Patents did Vitae Pharmaceuticals File Every Year?

Vitae Pharmaceuticals Patent Filing Trend Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant Vitae Pharmaceuticals Applications Filed Vitae Pharmaceuticals Patents Granted
2023 2 11
2022 8 14
2021 9 37
2020 25 29
2019 16 39
2018 54 17
2017 78 44
2016 55 54
2015 89 57
2014 23 53
2013 122 58
 

How many Vitae Pharmaceuticals patents are Alive/Dead?

Worldwide Patents Vitae Pharmaceuticals Patent Portfolio

How Many Patents did Vitae Pharmaceuticals File in Different Countries?

Vitae Pharmaceuticals Worldwide Patent Filing

Countries in which Vitae Pharmaceuticals Filed Patents

Country Patents
United States Of America 123
Europe 65
Japan 63
Canada 43
Germany 37
Austria 34
Hong Kong (S.A.R.) 29
Mexico 28
Australia 27
Israel 26
India 25
Brazil 24
Korea (South) 24
Taiwan 22
Argentina 21
Singapore 19
South Africa 19
China 18
Chile 18
New Zealand 15
Philippines 14
Spain 13
Denmark 12
Malaysia 12
Indonesia 11
Peru 11
Uruguay 9
Viet Nam 8
Colombia 8
Tunisia 7
Slovenia 7
Malta 7
Morocco 7
Poland 7
Portugal 7
Norway 7
Croatia 6
Estonia 6
Albania 6
Hungary 6
Ecuador 6
Serbia 5
Italy 5
Slovakia 5
Cyprus 4
Africa 4
Lithuania 4
Russia 4
Georgia 4
Eurasia 3
Montenegro 3
San Marino 3
Gulf Cooperation Council 2
Saudi Arabia 2
Thailand 1
Finland 1
Macao 1
Former Yugoslav Republic of Macedonia 1
Africa 1

Where are Research Centers of Vitae Pharmaceuticals Patents Located?

R&D Centers of Vitae Pharmaceuticals

 10 Best Vitae Pharmaceuticals Patents

WO2009017664A1 is the most popular patent in the Vitae Pharmaceuticals portfolio. It has received 128 citations so far from companies like Sanofi, Glaxo Group Limited and Abbott Laboratories.

Below is the list of 10 most cited patents of Vitae Pharmaceuticals:

Publication Number Citation Count
WO2009017664A1 128
WO2009134400A1 109
WO2015164573A1 103
WO2015116904A1 102
WO2009108332A1 96
WO2009061498A1 76
WO2010011314A1 76
WO2016061160A1 74
WO2009117109A1 72
WO2017112768A1 71

What Percentage of Vitae Pharmaceuticals US Patent Applications were Granted?

Vitae Pharmaceuticals (Excluding its subsidiaries) has filed 36 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 30 have been granted leading to a grant rate of 88.24%. Below are the key stats of Vitae Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Vitae Pharmaceuticals?

Law Firm Total Applications Success Rate
Mccarter & English 31 86.67%
Cooley 4 100.00%
Allergan 1 100.00%

What are Vitae Pharmaceuticals key innovation segments?

What Technologies are Covered by Vitae Pharmaceuticals?

The chart below distributes patents filed by Vitae Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Vitae Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Vitae Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Vitae Pharmaceuticals?

Related Articles

Luzerne Patents – Insights & Stats (Updated 2024)

Luzerne has a total of 9 patents globally, out of which all patents have been granted. Of these 9 patents, all patents are active. Singapore is where Luzerne has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the origin

Read More »

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.